Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1977 Jun 4;116(11):1257–1260.

Reversible dysfunction of T-lymphocytes in common variable immunodeficiency.

W H Marshall, P W Allderdice, H W Edstrom, R M Newton, E Pike
PMCID: PMC1879271  PMID: 140758

Abstract

A 30-year-old man with recurrent sinopulmonary infections, eventually fatal, was found to have common variable immunodeficiency. In addition to low serum immunoglobulin concentrations he also had lymphopenia and cell-mediated immunodeficiency as shown by cutaneous anergy and a poor lymphocyte response to phytohemagglutinin (PHA) in vitro. However, intradermal injection of PHA produced a vigorous cutaneous response, showing that some cell-mediated responsiveness remained. The responsiveness of his lymphocytes to PHA was restored towards normal (confirmed by chromosome studies) by the addition of a small number of normal leukocytes to cultures; thus a reversible functional defect in his T-lymphocytes was revealed. Experiments indicated that the defect was cellular and not due to serum factors and it was concluded that normal leukocytes restored a missing factor to the patient's T-lymphocytes. Although counts of macrophage precursor cells in the bloodstream were low, thus contributing to the immunodeficiency, this could not have caused the reduced PHA response. Several relatives of this patient had lymphoma; two cousins had common variable immunodeficiency.

Full text

PDF
1257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buehler S. K., Firme F., Fodor G., Fraser G. R., Marshall W. H., Vaze P. Common variable immunodeficiency, Hodgkin's disease, and other malignancies in a Newfoundland family. Lancet. 1975 Jan 25;1(7900):195–197. doi: 10.1016/s0140-6736(75)91361-6. [DOI] [PubMed] [Google Scholar]
  2. Cooper M. D., Lawton A. R., Bockman D. E. Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation. Lancet. 1971 Oct 9;2(7728):791–794. doi: 10.1016/s0140-6736(71)92742-5. [DOI] [PubMed] [Google Scholar]
  3. Geha R. S., Schneeberger E., Merler E., Rosen F. S. Heterogeneity of "acquired" or common variable agammaglobulinemia. N Engl J Med. 1974 Jul 4;291(1):1–6. doi: 10.1056/NEJM197407042910101. [DOI] [PubMed] [Google Scholar]
  4. Krikorian G., Marshall W. H., Simmons S., Stratton F. Counts and characteristics of macrophage precursors in human peripheral blood. Cell Immunol. 1975 Sep;19(1):22–31. doi: 10.1016/0008-8749(75)90288-9. [DOI] [PubMed] [Google Scholar]
  5. Lubaroff D. M., Waksman B. H. Bone marrow as source of cells in reactions of cellular hypersensitivity. II. Identification of allogeneic or hybrid cells by immunofluorescence in passively transferred tuberculin reactions. J Exp Med. 1968 Dec 1;128(6):1437–1447. doi: 10.1084/jem.128.6.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marshall W. H., Newton R. M., Sprague W. Attempt to restore lymphocytes with defective T-cell function by mixing with normal cells in vitro. Can Med Assoc J. 1973 Jun 2;108(11):1381–1384. [PMC free article] [PubMed] [Google Scholar]
  7. Marshall W. H., Rigo S. J., Melman S. Lymphocyte transformation and mitosis in vitro initiated by homologous macrophages. An improved method for histocompatibility testing. Lancet. 1966 Apr 2;1(7440):730–732. doi: 10.1016/s0140-6736(66)90889-0. [DOI] [PubMed] [Google Scholar]
  8. Marshall W. H., Valentine F. T., Lawrence H. S. Cellular immunity in vitro. Clonal proliferation of antigen-stimulated lymphocytes. J Exp Med. 1969 Aug 1;130(2):327–343. doi: 10.1084/jem.130.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oppenheim J. J., Leventhal B. G., Hersh E. M. The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol. 1968 Aug;101(2):262–267. [PubMed] [Google Scholar]
  10. VOLKMAN A., GOWANS J. L. THE ORIGIN OF MACROPHAGES FROM BONE MARROW IN THE RAT. Br J Exp Pathol. 1965 Feb;46:62–70. [PMC free article] [PubMed] [Google Scholar]
  11. WOLLHEIM F. A., BELFRAGE S., COESTER C., LINDHOLM H. PRIMARY "ACQUIRED" HYPOGAMMAGLOBULINEMIA; CLINICAL AND GENETIC ASPECTS OF NINE CASES. Acta Med Scand. 1964 Jul;176:1–16. [PubMed] [Google Scholar]
  12. Waldmann T. A., Durm M., Broder S., Blackman M., Blaese R. M., Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974 Sep 14;2(7881):609–613. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]
  13. Wernet P., Siegal F. P., Dickler H., Fu S., Kunkel H. G. Immunoglobulin synthesis in vitro by lymphocytes from patients with immune deficiency: requirements for a special serum factor. Proc Natl Acad Sci U S A. 1974 Feb;71(2):531–535. doi: 10.1073/pnas.71.2.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wu L. Y., Lawton A. R., Cooper M. D. Differentiation capacity of cultured B lymphocytes from immunodeficient patients. J Clin Invest. 1973 Dec;52(12):3180–3189. doi: 10.1172/JCI107518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. de la Concha E. G., Oldham G., Webster A. D., Asherson G. L., Platts-Mills T. A. Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol. 1977 Feb;27(2):208–215. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES